<bill session="116" type="s" number="3162" updated="2020-11-19T06:14:50Z">
  <state datetime="2020-01-08">REFERRED</state>
  <status>
    <introduced datetime="2020-01-08"/>
  </status>
  <introduced datetime="2020-01-08"/>
  <titles>
    <title type="short" as="introduced">Affordable Drug Manufacturing Act of 2020</title>
    <title type="short" as="introduced">Affordable Drug Manufacturing Act of 2020</title>
    <title type="display">Affordable Drug Manufacturing Act of 2020</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to establish an Office of Drug Manufacturing.</title>
  </titles>
  <sponsor bioguide_id="W000817"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-01-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-01-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="5501"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Competition and antitrust"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Federal officials"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health care quality"/>
    <term name="Health programs administration and funding"/>
    <term name="Inflation and prices"/>
    <term name="Licensing and registrations"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Public participation and lobbying"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
